IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i12p7417-d840533.html
   My bibliography  Save this article

Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019

Author

Listed:
  • Anju Murayama

    (Medical Governance Research Institute, Minato-ku 108-0074, Tokyo, Japan
    School of Medicine, Tohoku University, Sendai City 980-8577, Miyagi, Japan)

  • Sae Kamamoto

    (Medical Governance Research Institute, Minato-ku 108-0074, Tokyo, Japan
    School of Medicine, Hamamatsu University, Hamamatsu City 431-2102, Shizuoka, Japan)

  • Hiroaki Saito

    (Department of Gastroenterology, Sendai Kosei Hospital, Sendai City 980-0873, Miyagi, Japan)

  • Kohki Yamada

    (Medical Governance Research Institute, Minato-ku 108-0074, Tokyo, Japan)

  • Divya Bhandari

    (Medical Governance Research Institute, Minato-ku 108-0074, Tokyo, Japan)

  • Iori Shoji

    (Medical Governance Research Institute, Minato-ku 108-0074, Tokyo, Japan)

  • Hanano Mamada

    (Medical Governance Research Institute, Minato-ku 108-0074, Tokyo, Japan)

  • Moe Kawashima

    (Medical Governance Research Institute, Minato-ku 108-0074, Tokyo, Japan)

  • Erika Yamashita

    (Medical Governance Research Institute, Minato-ku 108-0074, Tokyo, Japan)

  • Eiji Kusumi

    (Navitas Clinic Shinjuku, Shinjuku-ku 160-0022, Tokyo, Japan)

  • Toyoaki Sawano

    (Department of Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki City 972-8322, Fukushima, Japan)

  • Binaya Sapkota

    (Nobel College Faculty of Health Sciences, Pokhara University, Kathmandu 33700, Nepal)

  • Tetsuya Tanimoto

    (Medical Governance Research Institute, Minato-ku 108-0074, Tokyo, Japan
    Department of Internal Medicine, Navitas Clinic, Tachikawa City 160-0022, Tokyo, Japan)

  • Akihiko Ozaki

    (Medical Governance Research Institute, Minato-ku 108-0074, Tokyo, Japan
    Department of Breast and Thyroid Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki City 972-8322, Fukushima, Japan)

Abstract

Backgrounds: Conflict of interest with pharmaceutical companies is one of the most concerned issues in infectious diseases. However, there is a lack of whole picture of detailed payments in Japan. Methods: This retrospective study assessed financial relationships between pharmaceutical companies and all infectious disease specialists board-certified by the Japanese Association for Infectious Disease, using publicly disclosed payment data from 92 major pharmaceutical companies. Descriptive analyses were conducted for the payments. Payment trends were examined by the generalized estimating equations. Results: Of 1614 board-certified infection disease specialists, 1055 (65.4%) received a total of $17,784,070 payments, corresponding to 21,680 contracts between 2016 and 2019. The mean ± SD and median (interquartile range: IQR) were $16,857 ± $45,010 and $3183 ($938–$11,250) in payments. All board executive members of Japanese Association of Infectious Disease received higher payments averaging $163,792. There were no significant changes in payments per specialist (annual change rate: −1.4% [95% CI: −4.7–2.3%], p = 0.48) and prevalence of specialists with payments (annual change rate: −1.4% [95% CI: −3.1–0.2%], p = 0.093) over the four years. Conclusion: There were substantial financial relationships between pharmaceutical companies and board-certified infectious disease specialists in Japan. Furthermore, high ranked specialists such as those in the executive board had stronger financial ties with the companies.

Suggested Citation

  • Anju Murayama & Sae Kamamoto & Hiroaki Saito & Kohki Yamada & Divya Bhandari & Iori Shoji & Hanano Mamada & Moe Kawashima & Erika Yamashita & Eiji Kusumi & Toyoaki Sawano & Binaya Sapkota & Tetsuya Ta, 2022. "Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019," IJERPH, MDPI, vol. 19(12), pages 1-13, June.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:12:p:7417-:d:840533
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/12/7417/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/12/7417/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Roy H Perlis & Clifford S Perlis, 2016. "Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs," PLOS ONE, Public Library of Science, vol. 11(5), pages 1-12, May.
    2. Genevieve Pham-Kanter, 2014. "Act II of the Sunshine Act," PLOS Medicine, Public Library of Science, vol. 11(11), pages 1-3, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Toon van der Gronde & Carin A Uyl-de Groot & Toine Pieters, 2017. "Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-34, August.
    2. Susan F Wood & Joanna Podrasky & Meghan A McMonagle & Janani Raveendran & Tyler Bysshe & Alycia Hogenmiller & Adriane Fugh-Berman, 2017. "Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia," PLOS ONE, Public Library of Science, vol. 12(10), pages 1-13, October.
    3. Ozaki, Akihiko & Saito, Hiroaki & Senoo, Yuki & Sawano, Toyoaki & Shimada, Yuki & Kobashi, Yurie & Yamamoto, Kana & Suzuki, Yosuke & Tanimoto, Tetsuya, 2020. "Overview and transparency of non-research payments to healthcare organizations and healthcare professionals from pharmaceutical companies in Japan: Analysis of payment data in 2016," Health Policy, Elsevier, vol. 124(7), pages 727-735.
    4. Anju Murayama & Yuki Senoo & Kayo Harada & Yasuhiro Kotera & Hiroaki Saito & Toyoaki Sawano & Yosuke Suzuki & Tetsuya Tanimoto & Akihiko Ozaki, 2022. "Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians," IJERPH, MDPI, vol. 19(6), pages 1-24, March.
    5. Thomas Lebesmuehlbacher & Rhet A. Smith, 2021. "The effect of medical cannabis laws on pharmaceutical marketing to physicians," Health Economics, John Wiley & Sons, Ltd., vol. 30(10), pages 2409-2436, September.
    6. Ansari, Bahareh, 2021. "Industry payments and physicians prescriptions: Effect of a payment restriction policy," Social Science & Medicine, Elsevier, vol. 278(C).
    7. Waqas Haque & Abu Minhajuddin & Arjun Gupta & Deepak Agrawal, 2018. "Conflicts of interest of editors of medical journals," PLOS ONE, Public Library of Science, vol. 13(5), pages 1-12, May.
    8. Rose, Susannah L. & Sah, Sunita & Dweik, Raed & Schmidt, Cory & Mercer, MaryBeth & Mitchum, Ariane & Kattan, Michael & Karafa, Matthew & Robertson, Christopher, 2021. "Patient responses to physician disclosures of industry conflicts of interest: A randomized field experiment," Organizational Behavior and Human Decision Processes, Elsevier, vol. 166(C), pages 27-38.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:12:p:7417-:d:840533. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.